首页 > 最新文献

Annals of Neurosciences最新文献

英文 中文
Recent Progress in the Development of New Antiepileptic Drugs with Novel Targets. 新型靶点抗癫痫药物的研究进展
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-08-17 DOI: 10.1177/09727531231185991
Tafere Mulaw Belete
Background Epilepsy is a chronic neurological disorder that affects approximately 50–70 million people worldwide. Epilepsy has a significant economic and social burden on patients as well as on the country. The recurrent, spontaneous seizure activity caused by abnormal neuronal firing in the brain is a hallmark of epilepsy. The current antiepileptic drugs provide symptomatic relief by restoring the balance of excitatory and inhibitory neurotransmitters. Besides, about 30% of epileptic patients do not achieve seizure control. The prevalence of adverse drug reactions, including aggression, agitation, irritability, and associated comorbidities, is also prevalent. Therefore, researchers should focus on developing more effective, safe, and disease-modifying agents based on new molecular targets and signaling cascades. Summary This review overviews several clinical trials that help identify promising new targets like lactate dehydrogenase inhibitors, c-jun n-terminal kinases, high mobility group box-1 antibodies, astrocyte reactivity inhibitors, cholesterol 24-hydroxylase inhibitors, glycogen synthase kinase-3 beta inhibitors, and glycolytic inhibitors to develop a new antiepileptic drug. Key messages Approximately 30% of epileptic patients do not achieve seizure control. The current anti-seizure drugs are not disease modifying, cure or prevent epilepsy. Lactate dehydrogenase inhibitor, cholesterol 24-hydroxylase inhibitor, glycogen synthase kinase-3 beta inhibitors, and mTOR inhibitors have a promising antiepileptogenic effect.
癫痫是一种慢性神经系统疾病,影响着全球约5000万至7000万人。癫痫给患者和国家带来了巨大的经济和社会负担。由大脑中异常神经元放电引起的反复自发癫痫活动是癫痫的标志。目前的抗癫痫药物通过恢复兴奋性和抑制性神经递质的平衡来缓解症状。此外,大约30%的癫痫患者没有达到癫痫控制。药物不良反应的发生率也很普遍,包括攻击性、烦躁、易怒和相关的合并症。因此,研究人员应该专注于开发基于新的分子靶标和信号级联的更有效、安全和疾病修饰剂。这篇综述综述了几项临床试验,这些试验有助于确定有前景的新靶点,如乳酸脱氢酶抑制剂、c-jun n端激酶、高迁移率组box-1抗体、星形胶质细胞反应性抑制剂、胆固醇24-羟化酶抑制剂、糖原合酶激酶-3β抑制剂和糖酵解抑制剂,以开发一种新的抗癫痫药物。大约30%的癫痫患者无法控制癫痫发作。目前的抗癫痫药物并不能改变、治愈或预防癫痫。乳酸脱氢酶抑制剂、胆固醇24-羟化酶抑制剂、糖原合成酶激酶-3β抑制剂和mTOR抑制剂具有良好的抗癫痫作用。
{"title":"Recent Progress in the Development of New Antiepileptic Drugs with Novel Targets.","authors":"Tafere Mulaw Belete","doi":"10.1177/09727531231185991","DOIUrl":"10.1177/09727531231185991","url":null,"abstract":"Background Epilepsy is a chronic neurological disorder that affects approximately 50–70 million people worldwide. Epilepsy has a significant economic and social burden on patients as well as on the country. The recurrent, spontaneous seizure activity caused by abnormal neuronal firing in the brain is a hallmark of epilepsy. The current antiepileptic drugs provide symptomatic relief by restoring the balance of excitatory and inhibitory neurotransmitters. Besides, about 30% of epileptic patients do not achieve seizure control. The prevalence of adverse drug reactions, including aggression, agitation, irritability, and associated comorbidities, is also prevalent. Therefore, researchers should focus on developing more effective, safe, and disease-modifying agents based on new molecular targets and signaling cascades. Summary This review overviews several clinical trials that help identify promising new targets like lactate dehydrogenase inhibitors, c-jun n-terminal kinases, high mobility group box-1 antibodies, astrocyte reactivity inhibitors, cholesterol 24-hydroxylase inhibitors, glycogen synthase kinase-3 beta inhibitors, and glycolytic inhibitors to develop a new antiepileptic drug. Key messages Approximately 30% of epileptic patients do not achieve seizure control. The current anti-seizure drugs are not disease modifying, cure or prevent epilepsy. Lactate dehydrogenase inhibitor, cholesterol 24-hydroxylase inhibitor, glycogen synthase kinase-3 beta inhibitors, and mTOR inhibitors have a promising antiepileptogenic effect.","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662271/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47551373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Yoga vs Physical Therapy in Multiple Sclerosis: Results of Randomized Controlled Trial and the Training Protocol. 瑜伽与物理治疗多发性硬化症:随机对照试验和训练方案的结果
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-04-12 DOI: 10.1177/09727531231161994
Elena Lysogorskaia, Timur Ivanov, Ainagul Mendalieva, Elena Ulmasbaeva, Maxim Youshko, Lev Brylev

Background: Yoga originated in the territory of modern India more than 3,000 years ago uses techniques for working with the musculoskeletal system, cardiorespiratory system, and attention. Currently, the effectiveness and safety of yoga in patients with various neurological disorders, including multiple sclerosis (MS), is of interest to many scientists and clinicians.

Purpose: The main aim of this study is to examine the effect of yoga on symptoms and quality of life in patients with MS vs physical therapy (exercise therapy) and no exercise.

Methods: The patients were randomly assigned to three groups (yoga, physical therapy (PT), or waiting list). After 12 weeks of regular exercises (or the absence of them), the effect of yoga and PT on the functional status and quality of life of patients were evaluated. The data were collected during the patients' two visits to the study center - before the start of the study and at the end of the 12-week period. The in-person examination included a doctor's assessment of the Expanded Disability Status Scale (EDSS), the SF-36 quality of life questionnaire, the fatigue scale, the Berg balance scale, and the 6-min walking test.

Results: A total of 36 patients finished the clinical study: thirty women and six men. There was no statistically significant difference between the groups in terms of improvement in MS symptoms as measured by the balance, walking test, and fatigue scales. However, in the analysis of eight criteria of SF-36 quality-of-life questionnaire by the covariation analysis, statistically significant differences were found in favor of the yoga group in terms of physical functioning (PF) (p = .003), life activity (VT) (p < .001), mental health (MH) (p = 013), and social functioning (SF) (p = .028).

Conclusion: Thus, regular yoga classes under the guidance of qualified staff are a promising method of non-drug rehabilitation of patients with MS with motor disorders.

瑜伽起源于3000多年前的现代印度领土,使用的是与肌肉骨骼系统、心肺系统和注意力有关的技术。目前,瑜伽对包括多发性硬化症(MS)在内的各种神经系统疾病患者的有效性和安全性是许多科学家和临床医生感兴趣的问题。本研究的主要目的是研究瑜伽对多发性硬化症患者的症状和生活质量的影响,对比物理治疗(运动治疗)和不运动。患者被随机分为三组(瑜伽组、物理治疗组或等候组)。经过12周的定期运动(或不运动)后,评估瑜伽和PT对患者功能状态和生活质量的影响。这些数据是在患者两次访问研究中心期间收集的——在研究开始前和12周结束时。亲自检查包括医生对扩展残疾状态量表(EDSS)、SF-36生活质量问卷、疲劳量表、Berg平衡量表和6分钟步行测试的评估。共有36名患者完成了临床研究:30名女性和6名男性。通过平衡、行走测试和疲劳量表测量,两组之间在MS症状改善方面没有统计学上的显著差异。然而,在对SF-36生活质量问卷的8项指标进行共变分析时,瑜伽组在身体功能(PF) (p = 0.003)、生活活动(VT) (p < 0.001)、心理健康(MH) (p = 013)和社会功能(SF) (p = 0.028)方面差异有统计学意义。因此,在有资质的工作人员的指导下,定期上瑜伽课是一种很有希望的MS伴运动障碍患者非药物康复的方法。
{"title":"Yoga vs Physical Therapy in Multiple Sclerosis: Results of Randomized Controlled Trial and the Training Protocol.","authors":"Elena Lysogorskaia, Timur Ivanov, Ainagul Mendalieva, Elena Ulmasbaeva, Maxim Youshko, Lev Brylev","doi":"10.1177/09727531231161994","DOIUrl":"10.1177/09727531231161994","url":null,"abstract":"<p><strong>Background: </strong>Yoga originated in the territory of modern India more than 3,000 years ago uses techniques for working with the musculoskeletal system, cardiorespiratory system, and attention. Currently, the effectiveness and safety of yoga in patients with various neurological disorders, including multiple sclerosis (MS), is of interest to many scientists and clinicians.</p><p><strong>Purpose: </strong>The main aim of this study is to examine the effect of yoga on symptoms and quality of life in patients with MS vs physical therapy (exercise therapy) and no exercise.</p><p><strong>Methods: </strong>The patients were randomly assigned to three groups (yoga, physical therapy (PT), or waiting list). After 12 weeks of regular exercises (or the absence of them), the effect of yoga and PT on the functional status and quality of life of patients were evaluated. The data were collected during the patients' two visits to the study center - before the start of the study and at the end of the 12-week period. The in-person examination included a doctor's assessment of the Expanded Disability Status Scale (EDSS), the SF-36 quality of life questionnaire, the fatigue scale, the Berg balance scale, and the 6-min walking test.</p><p><strong>Results: </strong>A total of 36 patients finished the clinical study: thirty women and six men. There was no statistically significant difference between the groups in terms of improvement in MS symptoms as measured by the balance, walking test, and fatigue scales. However, in the analysis of eight criteria of SF-36 quality-of-life questionnaire by the covariation analysis, statistically significant differences were found in favor of the yoga group in terms of physical functioning (PF) (<i>p</i> = .003), life activity (VT) (<i>p</i> < .001), mental health (MH) (<i>p</i> = 013), and social functioning (SF) (<i>p</i> = .028).</p><p><strong>Conclusion: </strong>Thus, regular yoga classes under the guidance of qualified staff are a promising method of non-drug rehabilitation of patients with MS with motor disorders.</p>","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662275/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47956331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Unveiling the Neurobiology of Specific Learning Disorders: Insights from Cognitive Neuroscience. 揭示特殊学习障碍的神经生物学:来自认知神经科学的见解。
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-11-20 DOI: 10.1177/09727531231211052
Satvinder Singh Saini, Krishan Kumar, Akshay Anand
{"title":"Unveiling the Neurobiology of Specific Learning Disorders: Insights from Cognitive Neuroscience.","authors":"Satvinder Singh Saini, Krishan Kumar, Akshay Anand","doi":"10.1177/09727531231211052","DOIUrl":"https://doi.org/10.1177/09727531231211052","url":null,"abstract":"","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662270/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138457376","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reproducibility and Reliability of Computing Models in Segmentation and Volumetric Measurement of Brain. 脑分割和体积测量中计算模型的再现性和可靠性
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-04-06 DOI: 10.1177/09727531231159959
Mahender Kumar Singh

Background: Segmentation and morphometric measurement of brain tissue and regions from non-invasive magnetic resonance images have clinical and research applications. Several software tools and models have been developed by different research groups which are increasingly used for segmentation and morphometric measurements. Variability in results has been observed in the imaging data processed with different neuroimaging pipelines which have increased the focus on standardization.

Purpose: The availability of several tools and models for brain morphometry poses challenges as an analysis done on the same set of data using different sets of tools and pipelines may result in different results and interpretations and there is a need for understanding the reliability and accuracy of such models.

Methods: T1-weighted (T1-w) brain volumes from the publicly available OASIS3 dataset have been analysed using recent versions of FreeSurfer, FSL-FAST, CAT12, and ANTs pipelines. grey matter (GM), white matter (WM), and estimated total intracranial volume (eTIV) have been extracted and compared for inter-method variability and accuracy.

Results: All four methods are consistent and strongly reproducible in their measurement across subjects however there is a significant degree of variability between these methods.

Conclusion: CAT12 and FreeSurfer methods have the highest degree of agreement in tissue class segmentation and are most reproducible compared to others.

非侵入性磁共振图像对脑组织和脑区进行分割和形态测量具有临床和研究应用价值。不同的研究小组开发了一些软件工具和模型,这些工具和模型越来越多地用于分割和形态测量。在不同的神经成像管道处理的成像数据中观察到结果的可变性,这增加了对标准化的关注。脑形态测量学的几种工具和模型的可用性带来了挑战,因为使用不同的工具和管道对同一组数据进行分析可能会产生不同的结果和解释,并且需要了解这些模型的可靠性和准确性。使用最新版本的FreeSurfer、FSL-FAST、CAT12和ANTs管道分析了公开可用的OASIS3数据集的t1加权(T1-w)脑容量。提取灰质(GM)、白质(WM)和估计的总颅内容积(eTIV),并比较方法间的可变性和准确性。所有四种方法在不同受试者的测量中都是一致的,具有很强的可重复性,但这些方法之间存在很大程度的可变性。CAT12和FreeSurfer方法在组织分类分割中具有最高的一致性,并且与其他方法相比具有最高的可重复性。
{"title":"Reproducibility and Reliability of Computing Models in Segmentation and Volumetric Measurement of Brain.","authors":"Mahender Kumar Singh","doi":"10.1177/09727531231159959","DOIUrl":"10.1177/09727531231159959","url":null,"abstract":"<p><strong>Background: </strong>Segmentation and morphometric measurement of brain tissue and regions from non-invasive magnetic resonance images have clinical and research applications. Several software tools and models have been developed by different research groups which are increasingly used for segmentation and morphometric measurements. Variability in results has been observed in the imaging data processed with different neuroimaging pipelines which have increased the focus on standardization.</p><p><strong>Purpose: </strong>The availability of several tools and models for brain morphometry poses challenges as an analysis done on the same set of data using different sets of tools and pipelines may result in different results and interpretations and there is a need for understanding the reliability and accuracy of such models.</p><p><strong>Methods: </strong>T1-weighted (T1-w) brain volumes from the publicly available OASIS3 dataset have been analysed using recent versions of FreeSurfer, FSL-FAST, CAT12, and ANTs pipelines. grey matter (GM), white matter (WM), and estimated total intracranial volume (eTIV) have been extracted and compared for inter-method variability and accuracy.</p><p><strong>Results: </strong>All four methods are consistent and strongly reproducible in their measurement across subjects however there is a significant degree of variability between these methods.</p><p><strong>Conclusion: </strong>CAT12 and FreeSurfer methods have the highest degree of agreement in tissue class segmentation and are most reproducible compared to others.</p>","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42223966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Steroids in Headache: A Comprehensive Review of Recent Research. 类固醇治疗头痛:近期研究综述
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-06-01 DOI: 10.1177/09727531231173286
Priyanka V Kashyap, Sounak Chabri

Background: Headache is an extremely common symptom of the general outpatient department and also the headache clinic, with prevalence of 48.9% in the general population. None has ever experienced headache in life time. Headache is seen in 1 patient out of 10 general practitioner (GP) consultations, 1 referral out of 3 is headache in neurology OPD, and 1 in 5 of all emergency medical admissions. Of all headaches, around 98% constitute primary headache: migraine without aura, tension headache, and cluster headache. With advancement in various drug modalities, certain headache forms respond less well to the regular approved medications, and some headaches are complicated by the analgesic itself. Steroids have been tried in many subtypes of headache, especially in primary forms of headache with dysautonomia, headache with trigeminal pathway activation and disinhibition, and in certain medication-culprit headaches. This subgroup of headaches is almost a challenge in an emergency for the headache expert as well. So, we need to assess the role of steroids in less well-responsive headaches.

Summary: Current reviewed evidence on the role of steroids in primary headache suggests that steroids have a role in status migrainosus and medication overuse headache when used in the mentioned and monitored manner. Consideration and further exploration of its role in other primary headaches may reveal insight into steroid efficacy as a treatment modality in various subtypes of headache.

Key message: Steroids, when used cautiously in specifically selected primary headaches under supervision, proved miraculous where other modalities failed.

头痛是普通门诊和头痛门诊极为常见的症状,在普通人群中患病率为48.9%。没有人在一生中经历过头痛。每10名全科医生(GP)会诊中就有1名患者头痛,每3名神经内科门诊患者中就有1名头痛,每5名急诊患者中就有1名头痛。在所有头痛中,约98%为原发性头痛:无先兆偏头痛、紧张性头痛和丛集性头痛。随着各种药物形式的进步,某些头痛形式对常规批准的药物的反应不太好,有些头痛因止痛剂本身而复杂化。类固醇已被用于治疗许多类型的头痛,特别是原发性的伴有自主神经异常的头痛,伴有三叉神经通路激活和去抑制的头痛,以及某些药物引起的头痛。对于头痛专家来说,这类头痛在紧急情况下几乎是一个挑战。因此,我们需要评估类固醇在反应性较差的头痛中的作用。目前关于类固醇在原发性头痛中的作用的证据表明,当以上述和监测的方式使用类固醇时,类固醇在偏头痛状态和药物过度使用性头痛中起作用。考虑和进一步探索其在其他原发性头痛中的作用,可能会揭示类固醇作为各种亚型头痛治疗方式的疗效。当在监督下谨慎使用类固醇治疗特定的原发性头痛时,在其他治疗方式失败的情况下,类固醇被证明是奇迹。
{"title":"Steroids in Headache: A Comprehensive Review of Recent Research.","authors":"Priyanka V Kashyap, Sounak Chabri","doi":"10.1177/09727531231173286","DOIUrl":"10.1177/09727531231173286","url":null,"abstract":"<p><strong>Background: </strong>Headache is an extremely common symptom of the general outpatient department and also the headache clinic, with prevalence of 48.9% in the general population. None has ever experienced headache in life time. Headache is seen in 1 patient out of 10 general practitioner (GP) consultations, 1 referral out of 3 is headache in neurology OPD, and 1 in 5 of all emergency medical admissions. Of all headaches, around 98% constitute primary headache: migraine without aura, tension headache, and cluster headache. With advancement in various drug modalities, certain headache forms respond less well to the regular approved medications, and some headaches are complicated by the analgesic itself. Steroids have been tried in many subtypes of headache, especially in primary forms of headache with dysautonomia, headache with trigeminal pathway activation and disinhibition, and in certain medication-culprit headaches. This subgroup of headaches is almost a challenge in an emergency for the headache expert as well. So, we need to assess the role of steroids in less well-responsive headaches.</p><p><strong>Summary: </strong>Current reviewed evidence on the role of steroids in primary headache suggests that steroids have a role in status migrainosus and medication overuse headache when used in the mentioned and monitored manner. Consideration and further exploration of its role in other primary headaches may reveal insight into steroid efficacy as a treatment modality in various subtypes of headache.</p><p><strong>Key message: </strong>Steroids, when used cautiously in specifically selected primary headaches under supervision, proved miraculous where other modalities failed.</p>","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662276/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44980475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Spirulina in Structural Remodeling of Synapse in Telencephalon of Chronic Unpredictable Stress Model of Zebrafish. 螺旋藻在斑马鱼慢性应激模型端脑突触结构重建中的作用
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-04-07 DOI: 10.1177/09727531231166202
Harender Kumar, Vincy Garg, Kawalpreet Kaur, Ravneet Kaur

Background: Stress can affect the morphology and synaptic organization of the telencephalon. These structural changes at the cellular level can lead to the development of various psychopathologies.

Purpose: Given that the telencephalon plays a major role in stress responses, the current study aimed to investigate the role of Spirulina platensis as a neuroprotectant supplement in the early life of zebrafish in averting the alteration of synapse morphology in the telencephalon caused by chronic unpredictable stress (CUS) in the later stage.

Methods: 5dpf larvae were divided into two groups: one group was fed with a commercial fish diet and a second group with a 1% Spirulina-supplemented diet for 90 days. After 90 days, the adult zebrafish were exposed to CUS with different chronic stressors for 15 days. The synaptic plasticity was evaluated by morphometric analysis of synapse in telencephalon of zebrafish by transmission electron microscopy.

Results: The ultrastructural study demonstrated the protective role of Spirulina in the CUS model as no significant alterations in the length of the active zone, postsynaptic density, and synaptic cleft were observed as compared to the control group in the CUS model.

Conclusion: Thus, suggesting that the Spirulina supplementation can avert the remodeling effect of stress on synapse ultrastructure.

应激可以影响端脑的形态和突触组织。这些细胞水平的结构变化可以导致各种精神病理学的发展。鉴于端脑在应激反应中起着重要作用,本研究旨在研究钝顶螺旋藻作为斑马鱼早期生活中的神经保护剂补充剂在避免后期慢性不可预测应激(CUS)导致端脑突触形态改变方面的作用。5dpf幼虫分为两组:一组用商业鱼类日粮喂养,另一组用1%螺旋藻补充日粮喂养90天。90天后,成年斑马鱼暴露于具有不同慢性应激源的CUS中15天。用透射电镜对斑马鱼端脑突触进行形态计量学分析,评价其突触可塑性。超微结构研究证明了螺旋藻在CUS模型中的保护作用,因为与CUS模型的对照组相比,没有观察到活动区长度、突触后密度和突触间隙的显著变化。因此,补充螺旋藻可以避免应激对突触超微结构的重塑作用。
{"title":"Role of <i>Spirulina</i> in Structural Remodeling of Synapse in Telencephalon of Chronic Unpredictable Stress Model of Zebrafish.","authors":"Harender Kumar, Vincy Garg, Kawalpreet Kaur, Ravneet Kaur","doi":"10.1177/09727531231166202","DOIUrl":"10.1177/09727531231166202","url":null,"abstract":"<p><strong>Background: </strong>Stress can affect the morphology and synaptic organization of the telencephalon. These structural changes at the cellular level can lead to the development of various psychopathologies.</p><p><strong>Purpose: </strong>Given that the telencephalon plays a major role in stress responses, the current study aimed to investigate the role of <i>Spirulina platensis</i> as a neuroprotectant supplement in the early life of zebrafish in averting the alteration of synapse morphology in the telencephalon caused by chronic unpredictable stress (CUS) in the later stage.</p><p><strong>Methods: </strong>5dpf larvae were divided into two groups: one group was fed with a commercial fish diet and a second group with a 1% Spirulina-supplemented diet for 90 days. After 90 days, the adult zebrafish were exposed to CUS with different chronic stressors for 15 days. The synaptic plasticity was evaluated by morphometric analysis of synapse in telencephalon of zebrafish by transmission electron microscopy.</p><p><strong>Results: </strong>The ultrastructural study demonstrated the protective role of Spirulina in the CUS model as no significant alterations in the length of the active zone, postsynaptic density, and synaptic cleft were observed as compared to the control group in the CUS model.</p><p><strong>Conclusion: </strong>Thus, suggesting that the Spirulina supplementation can avert the remodeling effect of stress on synapse ultrastructure.</p>","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662278/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41298470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Neuropsychoeducation, Intrinsic Motivation, and Metaphoric Content Integrated with Cognitive Behavioral Therapy in the Treatment of Obsessive-Compulsive Disorder: A Pilot Study. 神经心理教育、内在动机、隐喻内容与认知行为疗法结合治疗强迫症的有效性:一项初步研究
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-04-06 DOI: 10.1177/09727531231160356
Atul Madaan, Mridula Mishra, Shinu Kochhar

Background: Obsessive-compulsive disorder (OCD) is considered frequent, unnecessary thoughts that lead to repetitive actions to lessen the apprehension provoked by thoughts; this repetitive sequence may further influence trouble in one's daily activities. The remedial procedure for OCD includes medication (such as SSRIs, anxiolytics, and antidepressants) with psychotherapy [such as cognitive behavioral therapy (CBT) and exposure response prevention (ERP)]. Previous investigations indicated that regardless of the trend of adopting CBT and ERP to treat OCD, only around half of the patients experienced a full reduction in symptoms.

Purpose: The ERP component in CBT has been termed as a challenging treatment as it contains threatening anxiety-provoking indications, and it has been reflected that between 25-30% of OCD patients reject the ERP treatment, and the refusal and dropout rates for ERP in OCD are higher than other interventions. Thus, in the present investigation, researchers developed a proposed therapy that includes neuropsychoeducation, intrinsic motivation, and metaphoric content integrated with CBT in addition to regular pharmacological management to treat OCD patients and validated the efficacy of the proposed therapy through psychometric ratings (Y-BOCS).

Method: In this pilot study, 10 cases of OCD received a 12-week proposed therapy program. The primary outcome was the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), which was assessed at baseline and post-treatment.

Results: The present study's results revealed a significant decrease in scores on the obsessions and compulsions domains and overall total scores on Y-BOCS among OCD patients.

Conclusion: The findings show that this proposed therapy, which includes neuropsychoeducation, intrinsic motivation, and metaphors contents integrated with CBT in combination with pharmacological management, is effective in the treatment of OCD. Therefore, the proposed therapy may be beneficial in the treatment of OCD. It has far-reaching implications in the areas of clinical, psychiatry, and mental health.

强迫症(OCD)被认为是频繁的、不必要的想法,会导致重复的行动,以减轻想法引发的恐惧;这种重复的顺序可能会进一步影响一个人日常活动中的麻烦。强迫症的治疗程序包括药物治疗(如SSRIs、抗焦虑药和抗抑郁药)和心理治疗[如认知行为疗法(CBT)和暴露反应预防(ERP)]。先前的研究表明,无论采用CBT和ERP治疗强迫症的趋势如何,只有大约一半的患者症状完全减轻。CBT中的ERP成分被称为一种具有挑战性的治疗方法,因为它包含威胁性的引发焦虑的指征,并且已经反映出25-30%的强迫症患者拒绝ERP治疗,并且强迫症中ERP的拒绝率和辍学率高于其他干预措施。因此,在本研究中,研究人员开发了一种拟议的治疗方法,该方法包括神经心理教育、内在动机和与CBT结合的隐喻内容,以及常规的药物管理,以治疗强迫症患者,并通过心理测量评分(Y-BOCS)验证了拟议治疗的疗效。在这项试点研究中,10例强迫症患者接受了为期12周的治疗计划。主要结果是Yale-Brown强迫症量表(Y-BOCS),该量表在基线和治疗后进行评估。本研究结果显示,强迫症患者在强迫症和强迫领域的得分以及Y-BOCS的总分显著下降。研究结果表明,该疗法包括神经心理教育、内在动机和隐喻内容,并结合CBT和药物管理,对强迫症的治疗是有效的。因此,所提出的治疗方法可能对强迫症的治疗有益。它在临床、精神病学和心理健康领域具有深远的影响。
{"title":"Effectiveness of Neuropsychoeducation, Intrinsic Motivation, and Metaphoric Content Integrated with Cognitive Behavioral Therapy in the Treatment of Obsessive-Compulsive Disorder: A Pilot Study.","authors":"Atul Madaan, Mridula Mishra, Shinu Kochhar","doi":"10.1177/09727531231160356","DOIUrl":"10.1177/09727531231160356","url":null,"abstract":"<p><strong>Background: </strong>Obsessive-compulsive disorder (OCD) is considered frequent, unnecessary thoughts that lead to repetitive actions to lessen the apprehension provoked by thoughts; this repetitive sequence may further influence trouble in one's daily activities. The remedial procedure for OCD includes medication (such as SSRIs, anxiolytics, and antidepressants) with psychotherapy [such as cognitive behavioral therapy (CBT) and exposure response prevention (ERP)]. Previous investigations indicated that regardless of the trend of adopting CBT and ERP to treat OCD, only around half of the patients experienced a full reduction in symptoms.</p><p><strong>Purpose: </strong>The ERP component in CBT has been termed as a challenging treatment as it contains threatening anxiety-provoking indications, and it has been reflected that between 25-30% of OCD patients reject the ERP treatment, and the refusal and dropout rates for ERP in OCD are higher than other interventions. Thus, in the present investigation, researchers developed a proposed therapy that includes neuropsychoeducation, intrinsic motivation, and metaphoric content integrated with CBT in addition to regular pharmacological management to treat OCD patients and validated the efficacy of the proposed therapy through psychometric ratings (Y-BOCS).</p><p><strong>Method: </strong>In this pilot study, 10 cases of OCD received a 12-week proposed therapy program. The primary outcome was the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS), which was assessed at baseline and post-treatment.</p><p><strong>Results: </strong>The present study's results revealed a significant decrease in scores on the obsessions and compulsions domains and overall total scores on Y-BOCS among OCD patients.</p><p><strong>Conclusion: </strong>The findings show that this proposed therapy, which includes neuropsychoeducation, intrinsic motivation, and metaphors contents integrated with CBT in combination with pharmacological management, is effective in the treatment of OCD. Therefore, the proposed therapy may be beneficial in the treatment of OCD. It has far-reaching implications in the areas of clinical, psychiatry, and mental health.</p>","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43183764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Need for Systematic Development and Validation of Yoga Modules in Yoga Research. 瑜伽研究中对瑜伽模块系统开发和验证的需求
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-08-30 DOI: 10.1177/09727531231192753
Nishitha Jasti, Naveen Gowrapura Halappa, Hemant Bhargav, Shivarama Varambally, Jagadisha Thirthalli
{"title":"Need for Systematic Development and Validation of Yoga Modules in Yoga Research.","authors":"Nishitha Jasti, Naveen Gowrapura Halappa, Hemant Bhargav, Shivarama Varambally, Jagadisha Thirthalli","doi":"10.1177/09727531231192753","DOIUrl":"10.1177/09727531231192753","url":null,"abstract":"","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662272/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46768124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flavanols for Age-related Memory Loss: A Promising Nutritional Intervention. 黄烷醇治疗与年龄相关的记忆丧失:一种有前途的营养干预
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-08-30 DOI: 10.1177/09727531231195683
Mariam Shahabi, Rahma Idrees
{"title":"Flavanols for Age-related Memory Loss: A Promising Nutritional Intervention.","authors":"Mariam Shahabi, Rahma Idrees","doi":"10.1177/09727531231195683","DOIUrl":"10.1177/09727531231195683","url":null,"abstract":"","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47565001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Viewing the Brain Through Retina: A New Avenue for Early Diagnosis of Alzheimer's Disease. 通过视网膜观察大脑:阿尔茨海默病早期诊断的新途径
IF 1.5 Q3 Neuroscience Pub Date : 2023-10-01 Epub Date: 2023-08-25 DOI: 10.1177/09727531231190992
Varisha Zuhair, Hussain Sohail Rangwala, Zaib Un Nisa Mughal, Hareer Fatima, Areeba Tufail Shaikh, Abdullah Mussarat
{"title":"Viewing the Brain Through Retina: A New Avenue for Early Diagnosis of Alzheimer's Disease.","authors":"Varisha Zuhair, Hussain Sohail Rangwala, Zaib Un Nisa Mughal, Hareer Fatima, Areeba Tufail Shaikh, Abdullah Mussarat","doi":"10.1177/09727531231190992","DOIUrl":"10.1177/09727531231190992","url":null,"abstract":"","PeriodicalId":7921,"journal":{"name":"Annals of Neurosciences","volume":null,"pages":null},"PeriodicalIF":1.5,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45485661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Neurosciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1